Related Experiment Video

Updated: Aug 17, 2026

Testing the Efficacy of Pharmacological Agents in a Pericardial Target Delivery Model in the Swine
10:05

Testing the Efficacy of Pharmacological Agents in a Pericardial Target Delivery Model in the Swine

Published on: July 7, 2016

HDL: the 'new' target of cardiovascular medicine

Tiziana Sampietro1, Federico Bigazzi, Beatrice Dal Pino

  • 1CNR Institute of Clinical Physiology, Via Moruzzi, 1-56010 Pisa, Italy. tizisamp@ifc.cnr.it

International Journal of Cardiology
|June 28, 2005
PubMed

Insights

Low high-density lipoprotein (HDL) levels are linked to cardiovascular disease and atherosclerosis. Research suggests HDL has anti-inflammatory properties, offering hope for future treatments.

Area of Science:

  • Cardiovascular Medicine
  • Lipid Metabolism
  • Immunology

Background:

  • Low high-density lipoprotein (HDL) plasma concentrations are causally linked to cardiovascular disease.
  • This condition affects approximately 10% of the general population and is the most common dyslipidemia in coronary disease patients.
  • Reduced HDL impairs cholesterol clearance from the vascular wall, promoting inflammation and atherosclerosis.

Purpose of the Study:

  • To explore the role of HDL in cardiovascular disease pathogenesis.
  • To investigate HDL's anti-inflammatory properties.
  • To review current and future therapeutic strategies for low HDL levels.

Main Methods:

  • Review of clinical, experimental, and epidemiological research.
  • Analysis of studies on HDL function in cholesterol metabolism and inflammation.
  • Examination of genetic and pharmacological approaches to increase HDL.

Main Results:

  • HDL plays a crucial role in reverse cholesterol transport and possesses anti-inflammatory activities.
  • HDL modulates the expression of acute phase proteins, influencing inflammatory responses.
  • Current therapies for raising HDL have limited efficacy, but emerging strategies show promise.

Conclusions:

  • Low HDL is a significant risk factor for cardiovascular disease and atherosclerosis.
  • HDL's anti-inflammatory properties are key to its protective role.
  • Future research in genetic and targeted pharmacological treatments may offer effective therapies for low HDL.

More Related Videos

Hydra, a Computer-Based Platform for Aiding Clinicians in Cardiovascular Analysis and Diagnosis07:51

Hydra, a Computer-Based Platform for Aiding Clinicians in Cardiovascular Analysis and Diagnosis

Published on: September 26, 2018

Related Concept Videos

Cardiovascular Drugs: Classification based on Therapeutic Indications01:18

Cardiovascular Drugs: Classification based on Therapeutic Indications

Cardiovascular diseases, encompassing a range of conditions, can significantly affect the heart's operations and the overall circulatory system. These conditions impair the heart's ability to pump blood, leading to a deficit in oxygen supply to crucial organs. Anomalies in the heart's electrical system, known as arrhythmias, can cause heartbeats to accelerate or slow down. Usually, heart rates increase during physical activity and decrease while resting or sleeping. However, frequent irregular...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
Ischemic Heart Disease: Overview01:17

Ischemic Heart Disease: Overview

Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and narrowing...
Pharmacogenomics: Identification of New Drug Targets01:29

Pharmacogenomics: Identification of New Drug Targets

Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...